Literature DB >> 1316449

Murine retrovirus-induced spongiform encephalomyelopathy: host and viral factors which determine the length of the incubation period.

M Czub1, F J McAtee, J L Portis.   

Abstract

A molecular clone of wild mouse ecotropic retrovirus CasBrE (clone 15-1) causes a spongiform neurodegenerative disease with a long incubation period, greater than or equal to 6 months. This virus infects the central nervous system (CNS) at low levels. In contrast, a chimeric virus, FrCasE, containing env and 3' pol sequences of 15-1 in a Friend murine leukemia virus background, infects the CNS at high levels and causes a rapid neurodegenerative disease with an incubation period of only 16 days. With both viruses, the induction of neurologic disease is dependent on inoculation during the perinatal period. Since the length of the incubation period of this disease appears to be a function of the relative level of CNS infection, we have attempted to identify the viral and host factors which determine the relative level of virus infection of the CNS. It was previously shown that the CNS is susceptible to infection only during the perinatal period (M. Czub, S. Czub, F. J. McAtee, and J. L. Portis, J. Virol. 65:2539-2544, 1991). Here we have found that the susceptibility of the CNS wanes progressively or gradually as a function of the age of the host, this age-dependent resistance being complete by 12 to 14 days of age. Utilizing a group of chimeric viruses, we found that the relative level of CNS infection achieved after inoculation of mice at 1 day of age was a function of the kinetics of virus replication and spread in peripheral organs. Viruses which reached peak viremia titers early (5 to 7 days of age) infected the CNS at high levels, and viruses which reached peak titers later infected the CNS at lower levels. Among the group of viruses examined in the current study, the kinetics of peripheral virus replication and spread appeared to be influenced primarily by sequences within the R-U5-5' leader region of the viral genome. These results suggested that the relative level of CNS infection was determined very early in life and appeared to be a function of a dynamic balance between the kinetics of virus replication in the periphery and a progressively developing restriction of virus replication in the CNS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316449      PMCID: PMC241107     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Spongiform polioencephalomyelopathy caused by a murine retrovirus. I. Pathogenesis of infection in newborn mice.

Authors:  B R Brooks; J R Swarz; R T Johnson
Journal:  Lab Invest       Date:  1980-11       Impact factor: 5.662

2.  Isolation of a neurotropic type C virus.

Authors:  J E Officer; N Tecson; J D Estes; E Fontanilla; R W Rongey; M B Gardner
Journal:  Science       Date:  1973-09-07       Impact factor: 47.728

3.  Role of immunity in age-related resistance to paralysis after murine leukemia virus infection.

Authors:  P M Hoffman; D S Robbins; H C Morse
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

4.  Physical mapping of the paralysis-inducing determinant of a wild mouse ecotropic neurotropic retrovirus.

Authors:  L DesGroseillers; M Barrette; P Jolicoeur
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

5.  Monoclonal antibodies specific for wild mouse neurotropic retrovirus: detection of comparable levels of virus replication in mouse strains susceptible and resistant to paralytic disease.

Authors:  F J McAtee; J L Portis
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

6.  Pathogenesis of paralysis and lymphoma associated with a wild mouse retrovirus infection. Part 1. Age- and dose-related effects in susceptible laboratory mice.

Authors:  P M Hoffman; S K Ruscetti; H C Morse
Journal:  J Neuroimmunol       Date:  1981-09       Impact factor: 3.478

7.  Infectious entry of murine retroviruses into mouse cells: evidence of a postadsorption step inhibited by acidic pH.

Authors:  J L Portis; F J McAtee; L H Evans
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

8.  Pathogenesis of the slow disease of the central nervous system associated with wild mouse virus. III. Role of input virus and MCF recombinants in disease.

Authors:  M B Oldstone; F Jensen; J Elder; F J Dixon; P W Lampert
Journal:  Virology       Date:  1983-07-15       Impact factor: 3.616

9.  Molecular cloning of infectious viral DNA from ecotropic neurotropic wild mouse retrovirus.

Authors:  P Jolicoeur; N Nicolaiew; L DesGroseillers; E Rassart
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

10.  A spontaneous lower motor neuron disease apparently caused by indigenous type-C RNA virus in wild mice.

Authors:  M B Gardner; B E Henderson; J E Officer; R W Rongey; J C Parker; C Oliver; J D Estes; R J Huebner
Journal:  J Natl Cancer Inst       Date:  1973-10       Impact factor: 13.506

View more
  23 in total

1.  Neural stem cells as engraftable packaging lines can mediate gene delivery to microglia: evidence from studying retroviral env-related neurodegeneration.

Authors:  W P Lynch; A H Sharpe; E Y Snyder
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Rebound from Inhibition: Self-Correction against Neurodegeneration?

Authors:  Shobhana Sivaramakrishnan; William P Lynch
Journal:  J Clin Cell Immunol       Date:  2017-03-13

3.  Brain infection by neuroinvasive but avirulent murine oncornaviruses.

Authors:  S Asković; F J McAtee; C Favara; J L Portis
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Retrovirus infection strongly enhances scrapie infectivity release in cell culture.

Authors:  Pascal Leblanc; Sandrine Alais; Isabel Porto-Carreiro; Sylvain Lehmann; Jacques Grassi; Graça Raposo; Jean Luc Darlix
Journal:  EMBO J       Date:  2006-05-25       Impact factor: 11.598

5.  Characterization of glycosylated Gag expressed by a neurovirulent murine leukemia virus: identification of differences in processing in vitro and in vivo.

Authors:  R Fujisawa; F J McAtee; J H Zirbel; J L Portis
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

6.  Neurologic disease induced by polytropic murine retroviruses: neurovirulence determined by efficiency of spread to microglial cells.

Authors:  S J Robertson; K J Hasenkrug; B Chesebro; J L Portis
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

Review 7.  Differential glycosylation of the Cas-Br-E env protein is associated with retrovirus-induced spongiform neurodegeneration.

Authors:  W P Lynch; A H Sharpe
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

8.  Protective efficacy of nonneutralizing monoclonal antibodies in acute infection with murine leukemia virus.

Authors:  S H Pincus; R Cole; R Ireland; F McAtee; R Fujisawa; J Portis
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Identification of a sequence in the unique 5' open reading frame of the gene encoding glycosylated Gag which influences the incubation period of neurodegenerative disease induced by a murine retrovirus.

Authors:  J L Portis; G J Spangrude; F J McAtee
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

10.  The neuroinvasiveness of a murine retrovirus is influenced by a dileucine-containing sequence in the cytoplasmic tail of glycosylated Gag.

Authors:  R Fujisawa; F J McAtee; K Wehrly; J L Portis
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.